Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Youbo Pharma Acquired by Jiuzhitang in $1 Billion Reverse Takeover

publication date: May 26, 2015
Mudanjiang Youbo Pharma agreed to be acquired by Jiuzhitang Co. in exchange for $1 billion of Jiuzhitang's stock. Both companies offer TCM products. The transaction is a reverse takeover with Youbo the surviving company. Zhenguo Li, the manager of Youbo, will purchase an additional 83.5 million shares of Jiuzhitang for $242 million, representing 14% of the new company. Combined with the shares from his Youbo stake, he will have a controlling 42% stake in the combined company. More details....

Stock Symbol: (SHZ: 000989)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here